Latest Europe News

Clean TeQ Water has landed a substantial Front End Engineering Design contract with Sunrise Energy Metals for the scandium recovery circuit at the Syerston Scandium Project, potentially worth A$5.4 million. The deal advances the engineering design following successful preliminary testwork and highlights Clean TeQ’s growing role in critical metals processing.

Corporate Travel Management (ASX:CTD) has posted a $17.7 million net profit for FY26, reversing a prior $348.5 million loss, supported by UK client settlements, new debt facilities, and a governance uplift program.

AdAlta’s partner SHcell has gained regulatory approval to provide the BZDS1901 CAR-T therapy to advanced mesothelioma patients in China’s Hainan Boao Lecheng special access zone, marking a key milestone in real-world data collection and treatment availability.

Corporate Travel Management (ASX:CTD) posted a $17.7 million profit for FY26, reversing a $348.5 million loss the previous year, driven by stronger earnings in ANZ and Europe and progress on UK customer settlements.

Li-S Energy has inked a strategic collaboration with Australian defence firm EPE, unlocking pathways to international defence markets for its ultra-lightweight lithium sulfur batteries.

Energy One Limited (ASX:EOL) reported a robust FY2026 with a 17% increase in recurring revenue and a 51% jump in net profit before tax, while preparing for a transformative acquisition of Gas Management Services Limited to deepen its European market presence.

Strickland Metals is reshaping its leadership team with key departures and appointments as it shifts focus from exploration to development at its Rogozna Project in Serbia.

Regener8 Resources appoints Dave Malesic as Managing Director and CEO, aiming to accelerate its Balkan exploration program and unlock value at the Srebrenica North Project.

Collins Foods posted record FY26 revenue and underlying profit, exited Taco Bell to focus on KFC growth, and outlined ambitious expansion plans in Germany and Australia.

Osteopore Limited’s half-year results show an 8% revenue drop driven by currency effects, while losses widen 14% as the company invests heavily in product development and market growth.

Invex Therapeutics posted a $1.35 million net loss for FY2026, driven by expanded R&D efforts and a deepening collaboration with Tessara Therapeutics targeting neurological diseases including Alzheimer’s. The company renewed its orphan drug status in Europe and restructured its board during the year.

Advance ZincTek posted an 11% rise in FY26 profit before tax to $2.247 million on 12.6% higher sales, driven by AI integration and US market strength. The company is set to enter residential battery manufacturing in FY27, leveraging its zinc oxide expertise.